Literature DB >> 21432496

Plasma fibrinogen, tissue plasminogen activator, plasminogen activator inhibitor 1, and their related factors in three Japanese population samples.

K A Koike1, H Iso, T Shimamoto, M Kudo, U Umemura, S Sato, Y Naito, M Iida, Y Komachi.   

Abstract

To examine population mean variations in plasma fibrinogen and fibrinolytic variables, and their rela tions with cardiovascular risk characteristics among Japanese middle-aged men, a cross-sectional study was conducted for a total of 245 men aged 50-59 years in three population-based samples: residents in rural communities of northeast and central Japan and urban white-collar workers. Age-adjusted mean value of plasma fibrinogen, tissue plasminogen activator antigen (t-PA antigen), plasminogen activator inhibitor 1 antigen (PAI-1 antigen) did not differ significantly among the populations. Mean value of tissue plasminogen activator activity (t-PA activity) was lower in central rural residents than in northeast rural men. According to multiple linear regression analyses, there were positive associations of t-PA and PAI-1 antigens with serum triglyceride levels, serum insulin and waist-hip ratio within each population and the total samples. A positive association between these fibrinolytic variables and usual ethanol intake was also observed. Smoking was significantly associated with plasma fibrinogen and PAI-1 antigen but not with t-PA antigen or activity. Activity of t-PA was inversely associated with body mass index, and a mean difference in t-PA activity was in part explained by a mean difference in body mass index. In conclusion, population mean values of plasma fibrinogen and fibrinolytic variables did not differ among three Japanese populations except for mean t-PA activity. Reduced fibrinolysis expressed as increased PAI-1 antigen was associated with smoking and the status of insulin resistance, such as high levels of serum insulin, serum triglycerides and waist-hip ratio.

Entities:  

Keywords:  Japanese; insulin resistance; plasama fibrinogen; plasminogen activator inhibitor 1; tissue plasminogen activator

Year:  1998        PMID: 21432496      PMCID: PMC2723365          DOI: 10.1007/BF02931707

Source DB:  PubMed          Journal:  Environ Health Prev Med        ISSN: 1342-078X            Impact factor:   3.674


  33 in total

1.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

2.  Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study.

Authors:  T W Meade; S Mellows; M Brozovic; G J Miller; R R Chakrabarti; W R North; A P Haines; Y Stirling; J D Imeson; S G Thompson
Journal:  Lancet       Date:  1986-09-06       Impact factor: 79.321

3.  [The evaluation and the results of cooperative cholesterol and triglyceride standardization program by WHO-CDC (author's transl)].

Authors:  M Nakamura; M Morita; E Yabuuchi; M Yukami; S Kuruma; C Kuritani; Y Kanatsu; E Nishiwaki; H Ueshima; M Iida; Y Komachi
Journal:  Rinsho Byori       Date:  1982-03

4.  Alcohol consumption and 17-year mortality in the Chicago Western Electric Company study.

Authors:  A R Dyer; J Stamler; O Paul; M Lepper; R B Shekelle; H McKean; D Garside
Journal:  Prev Med       Date:  1980-01       Impact factor: 4.018

5.  Plasma fibrinogen and its correlates in Japanese and US population samples.

Authors:  H Iso; A R Folsom; S Sato; K K Wu; T Shimamoto; K Koike; M Iida; Y Komachi
Journal:  Arterioscler Thromb       Date:  1993-06

6.  Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men.

Authors:  J Heinrich; L Balleisen; H Schulte; G Assmann; J van de Loo
Journal:  Arterioscler Thromb       Date:  1994-01

7.  Endogenous tissue-type plasminogen activator and risk of myocardial infarction.

Authors:  P M Ridker; D E Vaughan; M J Stampfer; J E Manson; C H Hennekens
Journal:  Lancet       Date:  1993-05-08       Impact factor: 79.321

8.  Daytime fluctuations in blood of tissue-type plasminogen activator (t-PA) and its fast-acting inhibitor (PAI-1).

Authors:  C Kluft; A F Jie; D C Rijken; J H Verheijen
Journal:  Thromb Haemost       Date:  1988-04-08       Impact factor: 5.249

9.  Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction.

Authors:  A Hamsten; U de Faire; G Walldius; G Dahlén; A Szamosi; C Landou; M Blombäck; B Wiman
Journal:  Lancet       Date:  1987-07-04       Impact factor: 79.321

10.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

View more
  1 in total

1.  Plasma Levels of Tissue-Type Plasminogen Activator (tPA) in Normal Aging and Alzheimer's Disease: Links With Cognition, Brain Structure, Brain Function and Amyloid Burden.

Authors:  Clémence Tomadesso; Sara Martinez de Lizarrondo; Carine Ali; Brigitte Landeau; Florence Mézenge; Audrey Perrotin; Vincent de La Sayette; Denis Vivien; Gaël Chételat
Journal:  Front Aging Neurosci       Date:  2022-06-07       Impact factor: 5.702

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.